Abstract
Background
To evaluate the short-term efficacy, lung function, and oxidative stress levels between the robotic-assisted thoracoscopic surgery (RATS) and video-assisted thoracoscopic surgery group (VATS) for non-small cell lung cancer (NSCLC).
Methods
We conducted a retrospective cohort study, selecting 248 NSCLC patients who underwent minimally invasive lobectomy at the Department of Thoracic Surgery, Gansu Provincial People’s Hospital, from August 2019 to February 2023. There were 105 patients in the RATS group and 143 patients in the VATS group. The patients in the two groups were subjected to 1:1 propensity score matching analysis (PSM), and the perioperative indicators were recorded. The levels of oxidative stress factors (superoxide dismutase, SOD; malondialdehyde, MDA) and inflammatory factors were measured 1 day before surgery and 3 days after surgery, respectively. Pulmonary function and patient quality of life were measured at 1 day preoperatively and 3 months postoperatively.
Results
There are 93 patients in each group after PSM. Compared to the VATS group, the RATS group had shorter operation time, less intraoperative blood loss, greater number and groups of lymph nodes cleared, and shorter postoperative hospital stay. The SOD level in the RATS group was higher and the MDA level was lower than that in the VATS group after surgery. Postoperative inflammatory cytokine levels were less elevated in the RATS group than in the VATS group. At 3 months postoperatively, FVC%, FEV1%, and GQOLI-74 scores were higher in the RATS group than in the VATS group.
Conclusion
Compared to VATS lobectomy, RATS lobectomy has the advantages of shorter operative time, lesser bleeding, more lymph node dissection, faster postoperative recovery, and lesser impact on postoperative lung function. It is also capable of reducing the postoperative oxidative stress and inflammatory response, which can improve patients’ quality of life.
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request. No additional data are available.
References
Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72(1):7–33
Yang CJ, Kumar A, Deng JZ, Raman V, Lui NS, D’Amico TA, Berry MF (2021) A national analysis of short-term outcomes and long-term survival following thoracoscopic versus open lobectomy for clinical stage II non-small-cell lung cancer. Ann Surg 273(3):595–605
Aiolfi A, Nosotti M, Micheletto G, Khor D, Bonitta G, Perali C, Marin J, Biraghi T, Bona D (2021) Pulmonary lobectomy for cancer: systematic review and network meta-analysis comparing open, video-assisted thoracic surgery, and robotic approach. Surgery 169(2):436–446
Wang Z, Pang L, Tang J, Cheng J, Chen N, Zhou J, Liu L (2019) Video-assisted thoracoscopic surgery versus muscle-sparing thoracotomy for non-small cell lung cancer: a systematic review and meta-analysis. BMC Surg 19(1):144
Long H, Tan Q, Luo Q, Wang Z, Jiang G, Situ D, Lin Y, Su X, Liu Q, Rong T (2018) Thoracoscopic surgery versus thoracotomy for lung cancer: short-term outcomes of a randomized trial. Ann Thorac Surg 105(2):386–392
Paul S, Sedrakyan A, Chiu YL, Nasar A, Port JL, Lee PC, Stiles BM, Altorki NK (2013) Outcomes after lobectomy using thoracoscopy vs thoracotomy: a comparative effectiveness analysis utilizing the nationwide inpatient sample database. Eur J Cardio-Thorac Surg 43(4):813–817
Kneuertz PJ, Cheufou DH, D’Souza DM, Mardanzai K, Abdel-Rasoul M, Theegarten D, Moffatt-Bruce SD, Aigner C, Merritt RE (2019) Propensity-score adjusted comparison of pathologic nodal upstaging by robotic, video-assisted thoracoscopic, and open lobectomy for non-small cell lung cancer. J Thorac Cardiovasc Surg 158(5):1457-1466.e2
Abbas AE (2018) Surgical management of lung cancer: history, evolution, and modern advances. Curr Oncol Rep 20(12):98
Toker A, Özyurtkan MO, Kaba E, Ayalp K, Demirhan Ö, Uyumaz E (2016) Robotic anatomic lung resections: the initial experience and description of learning in 102 cases. Surg Endosc 30(2):676–683
Liu J, Lin CS, Gan WQ, Zheng YB, Wu ZB, Zhao ZX, Gao ZL (2012) Effect of healthcare insurance policy on the quality of life of chronic hepatitis C patients receiving interferon α-2a plus ribavirin therapy. Exp Ther Med 3(6):1062–1066
Nelson DB, Mehran RJ, Mitchell KG, Rajaram R, Correa AM, Bassett RL Jr, Antonoff MB, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Walsh GL, Vaporciyan AA, Rice DC (2019) Robotic-assisted lobectomy for non-small cell lung cancer: a comprehensive institutional experience. Ann Thorac Surg 108(2):370–376
Li JT, Liu PY, Huang J, Lu PJ, Lin H, Zhou QJ, Luo QQ (2019) Perioperative outcomes of radical lobectomies using robotic-assisted thoracoscopic technique vs. video-assisted thoracoscopic technique: retrospective study of 1075 consecutive p-stage I non-small cell lung cancer cases. J Thoracic Dis 11(3):882–891
Ottolenghi S, Sabbatini G, Brizzolari A, Samaja M, Chiumello D (2020) Hyperoxia and oxidative stress in anesthesia and critical care medicine. Minerva Anestesiol 86(1):64–75
Ercan M, Alp HH, Kocaturk H, Bakan N, Gul M (2019) Oxidative stress before and after surgery in benign prostatic hyperplasia patients. Andrologia 51(8):e13326
Nagamatsu Y, Maeshiro K, Kimura NY, Nishi T, Shima I, Yamana H, Shirouzu K (2007) Long-term recovery of exercise capacity and pulmonary function after lobectomy. J Thorac Cardiovasc Surg 134(5):1273–1278
Nomori H, Cong Y, Sugimura H (2016) Systemic and regional pulmonary function after segmentectomy. J Thorac Cardiovasc Surg 152(3):747–753
Gu Z, Wang H, Mao T, Ji C, Xiang Y, Zhu Y, Xu P, Fang W (2018) Pulmonary function changes after different extent of pulmonary resection under video-assisted thoracic surgery. J Thorac Dis 10(4):2331–2337
Acknowledgements
N/A.
Funding
No.
Author information
Authors and Affiliations
Contributions
Conception and design: ZQH, YJG, and XCD; Administrative support: YJG; Provision of study materials or patients: QL, HCL, BQC, and YJL; Collection and assembly of data: XSW and TC; Data analysis and interpretation: DCJ; Revise the manuscript: ZQH, QL, HCL, YJG, and XCD; Manuscript writing: All authors; Final approval of manuscript: All authors.
Corresponding authors
Ethics declarations
Disclosures
The authors, Ziqiang Hong; Qing Liu; Hongchao Li; Baiqiang Cui; Tao Cheng; Yingjie Lu; Xusheng Wu; Dacheng Jin; Yunjiu Gou; and Xinchun Dong, have no conflicts of interest or financial ties to disclose.
Ethical approval
The study was reviewed by the Ethics Committee of Gansu Provincial Hospital, approval number: 2023-236.
Informed to consent
Informed consent was obtained from all individual participants included in the study necessary. Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hong, Z., Liu, Q., Li, H. et al. Effect of da Vinci robot versus thoracoscopic surgery on lung function and oxidative stress levels in NSCLC patients: a propensity score-matched study. Surg Endosc 38, 706–712 (2024). https://doi.org/10.1007/s00464-023-10577-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-023-10577-x